[Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis]

Insights

Rheumatoid arthritis patients have a higher cardiovascular risk than healthy individuals, as shown by both ATP III and Reynolds Risk Score. The Reynolds Risk Score better identifies moderate to high cardiovascular risk in RA patients for timely intervention.

Area of Science:

  • Cardiology
  • Rheumatology
  • Preventive Medicine

Background:

  • Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular complications (CVC).
  • Accurate risk assessment is crucial for timely intervention in RA patients.
  • Existing risk scores may not fully capture the cardiovascular risk in this population.

Purpose of the Study:

  • To compare the 10-year cardiovascular complication (CVC) risk assessed by the Adult Treatment Panel III (ATP III) and Reynolds Risk Score (RRS) in rheumatoid arthritis (RA) patients.
  • To determine the contribution of C-reactive protein (CRP) to CVC development in RA patients.
  • To evaluate the effectiveness of RRS in identifying RA patients needing closer cardiovascular monitoring.

Main Methods:

  • The study included 116 RA patients and 85 healthy controls, matched for age and cardiovascular risk factors.
  • 10-year CVC risk was calculated using ATP III and RRS.
  • Serum levels of total cholesterol, HDL cholesterol, and highly sensitive C-reactive protein (hs-CRP) were measured.

Main Results:

  • RA patients exhibited significantly higher 10-year CVC risk by both ATP III and RRS compared to controls (p < 0.05).
  • The Reynolds Risk Score identified a higher proportion of RA patients with moderate to high cardiovascular risk compared to ATP III, particularly in males.
  • A positive correlation was observed between RRS and carotid intima-media thickness in RA patients (r = 0.44; p < 0.001).

Conclusions:

  • The Reynolds Risk Score is a valuable tool for identifying RA patients at moderate to high cardiovascular risk.
  • Implementing RRS can facilitate timely and targeted cardiovascular medication in RA patients.
  • Further research may explore the role of hs-CRP in refining cardiovascular risk prediction in RA.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...